latest news in companies
Nintendo Defends Human Creativity Against the Surge of Automated Digital Content
Kyoto, Sunday, 8 November 2026.
Facing an explosion of free, computer-generated digital entertainment, Nintendo reaffirms that proprietary human creativity—not automated tools—is vital to maintaining its pricing power and competitive edge.
Why Rising AI Infrastructure Costs Prompted Riot Platforms' Valuation Trim
Castle Rock, Sunday, 8 November 2026.
Despite securing a massive $28 billion AI data center lease, analysts lowered Riot’s fair value to $28.34, citing mounting construction costs, higher interest rates, and long-term project debt reliance.
Woodside Overhauls Strategy with New Payout Policy and 500 Job Cuts
Perth, Sunday, 8 November 2026.
Addressing investor pressure, Woodside Energy unveiled a disciplined capital framework, tying shareholder payouts to operating cash flow while eliminating over 500 positions to deliver $400 million in annual structural savings.
How Millions of Discarded Jeans Are Being Converted into Home Insulation
New York, Sunday, 8 November 2026.
Celebrating 20 years, Cotton Incorporated’s Blue Jeans Go Green initiative has diverted over 2,720 metric tons of textile waste, transforming six million recycled garments into building insulation and sustainable packaging.
The Persuasion Playbook: Why Filmmaker Alex Gibney Links Elon Musk to Elizabeth Holmes
New York, Sunday, 8 November 2026.
Filmmaker Alex Gibney argues that Elon Musk and Elizabeth Holmes shared an identical superpower: projecting supreme confidence to convince investors of claims they knew were untrue.
Why Construction Delays in American Data Centers Threaten Tech Growth
New York, Sunday, 8 November 2026.
With thirty percent of planned American data centers delayed, chipmakers face an unexpected bottleneck: billions of dollars in advanced processors are ready, yet physical buildings to house them remain unbuilt.
Eli Lilly Drives Large-Cap Earnings Growth as Valuation Surpasses One Trillion Dollars
New York, Sunday, 8 November 2026.
Surging demand for obesity treatments propelled Eli Lilly past a $1.2 trillion market valuation, leading Wall Street analysts to project robust corporate earnings growth despite broader equity market volatility.